Depression drug related to ketamine wins endorsement of key advisory panel
DANIEL HULSHIZER/AP
The Johnson & Johnson drug was tested in combination with oral antidepressants as a therapy for treatment-resistant depression.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario